Shen Zhiqun, China Investment Association: Accelerate the formation of technology and finance service support system with equity investment as the mainstay. On December 13th, the 2024 Yangtze River Economic Belt (Gongqingcheng) Fund Innovation and Development Conference with the theme of "Science and Technology Innovation Empowers High-quality Development and Venture Capital Helps' 1269' Action Plan" was held in Gongqingcheng, Jiangxi Province. Shen Zhiqun, Chairman of the Venture Capital Committee of China Investment Association and Assistant to the former President of the Macro Institute of the National Development and Reform Commission, delivered a speech at the conference. Venture capital is an important capital force to promote scientific and technological innovation and industrial innovation. Especially under the impetus of policies, an ecological environment that fully supports and promotes the high-quality development of venture capital is gradually taking shape and constantly improving and optimizing. (SSE)Pacific Securities: Goldwind Technology's performance is expected to achieve rapid growth, with the first "buy" rating. Pacific Securities Research Report pointed out that with the profit recovery of wind turbine business and the contribution of wind farm investment and development and wind power service business, Goldwind Technology's (002202.SZ) performance is expected to achieve rapid growth. The first coverage gives a "buy" rating. Goldwind Technology has ranked first in the domestic wind power market for 13 consecutive years since 2011; However, in recent years, under the strong competitive pressure of wind turbine enterprises after the second line, their market share has declined. In the future, with the increase of market concentration, Goldwind Technology, as a leader, is expected to increase its share. At the end of the third quarter of 2024, the company's external order volume was 41.38GW, and sufficient in-hand order volume supported its share increase.Spot gold fell below $2,680 per ounce, down 1.38% in the day. COMEX gold futures fell 2.00% in the day and are now reported at $2701.50 per ounce.
Qin Xinghua, Anneng Logistics: Under the general tone of "Striving for Progress in Stability", the logistics industry is welcoming new opportunities for development. The Central Economic Work Conference was held in Beijing from December 11 to 12. The conference analyzed the current economic situation and deployed economic work in 2025. Qin Xinghua, founder, CEO and president of Anneng Logistics, said that this meeting has made various plans for economic work next year, and a comprehensive and systematic layout is of great significance to the overall improvement and sustainable development of the economy. The meeting put forward key measures such as "solidly promoting high-quality development", "expanding domestic demand in all directions" and establishing the implementation of "more active fiscal policy" and "moderately loose monetary policy", and finalized the general tone of "striving for progress while maintaining stability" for economic development in 2025. It is foreseeable that the economic and social development situation will be stable and good next year, and the high-quality development trend will become more prominent. "As an important link in the economic development chain, the logistics industry will usher in new development opportunities under this economic background." Qin Xinghua was encouraged by the development of the enterprise.SINOMACH Seiko: It is planned to invest 73.6 million yuan to build an industrialization project of superhard tool. The company plans to invest in the industrialization project of superhard tool, and the main body of implementation is SINOMACH Diamond (Henan) Co., Ltd., a holding subsidiary of the company holding 67% equity. The total investment of the project is 73.6 million yuan, and the project construction period is about 12 months.Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.
Chinese researchers have developed a new type of implantable cranial nerve probe. The reporter learned from Changchun Institute of Applied Chemistry, Chinese Academy of Sciences that Zhang Qiang, a researcher at the institute, and his collaborators have developed a new type of implantable hydrogel neural probe to realize long-term stable monitoring of cranial nerve signals, precise regulation of neural circuits, and preliminary exploration in the application of diagnosis and treatment of severe brain diseases. Related research results were recently published in the international academic journal Advanced Materials. (Xinhua News Agency)Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.Barclays: Raise the target price of Standard Chartered from 940p to 970p.
Strategy guide 12-14
Strategy guide 12-14